Budesonide oral - West Pharmaceutical Services
Latest Information Update: 19 Dec 2021
At a glance
- Originator West Pharmaceutical Services
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Crohn's disease; Ulcerative colitis
Most Recent Events
- 02 Aug 2004 This compound is still in active development
- 13 Jun 2001 Phase-I clinical trials for Crohn's disease in USA (PO)
- 13 Jun 2001 Phase-I clinical trials for Ulcerative colitis in USA (PO)